Simparica Trio Pet Chewable Tick & Flea Tablet

Simparica Trio (Sarolaner, Moxidectin & Pyrantel Specialized Multi-Parasite Matrix)

Simparica Trio is a high-potency veterinary pharmacological intervention specifically engineered for the clinical management of ectoparasitic infestations, localized endoparasitic dullness, and the restoration of a stabilized biological environment in canines. Utilizing a unique “Triple-Action Defense” delivery system, this formulation works by concurrently modulating the organized inhibition of arthropod neurotransmission and reinforcing the structural integrity of the systemic anti-helminthic response. By neutralizing the biochemical triggers of localized flea and tick proliferation and facilitating the organized stabilization of the cardiovascular and gastrointestinal landscape through a high-purity molecular complex, Simparica Trio effectively promotes a significant increase in parasitic clearance and a reduction in systemic infectious fatigue. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the canine matrix while promoting a stable, physiological recovery from environmental biological stressors.

Key Features

• Specifically formulated with an isoxazoline, a macrocyclic lactone, and a tetrahydropyrimidine to target the primary pathways of external and internal parasitic survival.
• Clinically recognized for its role in facilitating the natural optimization of the cardiovascular environment by providing 100% prevention of heartworm disease.
• Specifically engineered to reach therapeutic levels within the circulatory system, ensuring a robust defense against localized tick-borne pathogens and Lyme disease.
• Acts as a functional catalyst to stabilize the gastrointestinal environment and support the reduction of stress-related physical roundworm and hookworm infestations.
• Formulated as a stabilized, palatable chewable to address systemic exhaustion caused by chronic parasitic stress factors through a high-precision monthly delivery matrix.

Key Ingredients

• Sarolaner
• Moxidectin
• Pyrantel (as Pamoate)
• Hydrolyzed Soy Protein
• Stabilized Liver Flavoring

Precautions

• This is a high-potency veterinary pharmacological intervention. Use must be strictly dictated by a licensed veterinarian following a formal diagnostic assessment and heartworm screening.
• Inform your veterinarian regarding your pet’s neurological history; this class of constituents (isoxazolines) may modulate systemic markers leading to tremors or seizures in predisposed canines.
• This formulation is strictly engineered for canine use only; do not administer to feline or other species as it may modulate systemic markers inappropriately.
• Strictly for oral administration. Ensure the entire chewable is ingested to maintain the intended molecular purity and systemic concentration for the full 30-day cycle.
• Discontinue use immediately and consult a specialist if your pet develops persistent localized vomiting, acute lethargy, or signs of an acute hypersensitivity reaction.
• Keep the container tightly sealed and store in a cool, dry place (below 30°C). Protect from moisture to maintain the molecular stability of the active constituents.

How to Use

• The tablet should be administered as directed by your veterinarian. Ensure the pet’s weight-based dosage category is correctly identified prior to the intake of active pharmacological agents.
• Typically, application of one chewable tablet once per month constitutes the standard therapeutic dose for the restoration of physiological equilibrium.
• For optimal clinical results, administration should occur on approximately the same date each month to facilitate a consistent systemic response.
• Offer the tablet as a treat or facilitate the intended molecular delivery by including it in a small portion of food. Observe the pet to ensure complete consumption.
• Use as a standalone restorative intervention or as part of a comprehensive seasonal wellness plan as dictated by clinical requirements.
• Maintain a strict 12-month application schedule to document visible improvements in physiological markers and the restoration of systemic health.

Legal Disclaimer: Simparica Trio is a specialized veterinary pharmacological product. Individual results vary based on the animal’s baseline physiological state and response. This product is for use under professional veterinary guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.